Iradimed Corporation splits its revenue into 7 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was MRI Compatible IV Infusion Pumps at $8.7 million, 36% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
89
|
24
|
20
|
22
|
23
|
21
|
20
|
20
|
19
|
| Device Revenue |
—
|
—
|
—
|
—
|
—
|
16
share 73.5%
|
—
|
13
share 66.4%
|
—
|
| MRI Compatible IV Infusion Pumps |
—
|
9
share 35.9%
|
6
-21.5%
share 31.4%
|
8
share 34.9%
|
—
|
—
|
8
share 40.1%
|
—
|
—
|
| MRI Compatible Patient Vital Signs Monitoring Systems |
—
|
8
+16.5%
share 33.1%
|
—
|
7
share 32.3%
|
—
|
7
share 32.4%
|
6
share 29.1%
|
—
|
—
|
| Disposable Revenue |
—
|
5
+20.6%
share 20.6%
|
5
+14.0%
share 23.4%
|
5
-1.3%
share 22.2%
|
—
|
4
share 19.5%
|
4
share 20.6%
|
5
share 25.4%
|
—
|
| Services |
—
|
—
|
1
+6.7%
share 5.2%
|
1
+0.1%
share 4.7%
|
—
|
1
share 4.1%
|
1
share 4.9%
|
1
share 5.3%
|
—
|
| Amortized Revenue |
—
|
1
+30.7%
share 3.3%
|
1
+28.0%
share 3.7%
|
1
+17.7%
share 3.0%
|
—
|
1
share 2.9%
|
1
share 2.9%
|
1
share 2.9%
|
—
|
| Ferro Magnetic Detection Systems |
—
|
0
+27.8%
share 2.0%
|
1
+56.8%
share 3.7%
|
1
+48.6%
share 2.8%
|
—
|
0
share 1.8%
|
0
share 2.4%
|
0
share 2.1%
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IRMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Orlando, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1325618
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.